Inflammatory bowel disease Flashcards

1
Q

What is Crohn’s disease?

A

Crohn’s disease is a form of inflammatory bowel disease that commonly affects the terminal ileum and colon but may be seen anywhere from the mouth to anus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the cause of Crohn’s disease?

A

The cause is unknown but there is a strong genetic susceptibility.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What layers of the gastrointestinal tract are affected by Crohn’s disease?

A

Inflammation occurs in all layers, down to the serosa.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What complications are patients with Crohn’s disease prone to?

A

Patients with Crohn’s are prone to strictures, fistulas, and adhesions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What percentage of Crohn’s disease patients have small bowel involvement?

A

80% of patients have small bowel involvement, usually in the ileum.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the common presentations of Crohn’s disease?

A

Common presentations include weight loss, lethargy, diarrhoea, abdominal pain, and perianal disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What investigations are used for Crohn’s disease?

A

Investigations include raised inflammatory markers, increased faecal calprotectin, anaemia, and low vitamin B12 and vitamin D.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are common extra-intestinal features of Crohn’s disease?

A

Common extra-intestinal features include arthritis, erythema nodosum, episcleritis, and osteoporosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is Crohn’s disease?

A

Crohn’s disease is a form of inflammatory bowel disease that commonly affects the terminal ileum and colon but may be seen anywhere from the mouth to anus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What blood test correlates well with Crohn’s disease activity?

A

C-reactive protein correlates well with disease activity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the investigation of choice for Crohn’s disease?

A

Colonoscopy is the investigation of choice.

Features suggestive of Crohn’s include deep ulcers and skip lesions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What histological features are seen in Crohn’s disease?

A

Inflammation in all layers from mucosa to serosa, goblet cells, and granulomas.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the purpose of a small bowel enema in Crohn’s disease?

A

It has high sensitivity and specificity for examination of the terminal ileum.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What sign indicates strictures in Crohn’s disease during a small bowel enema?

A

‘Kantor’s string sign’ indicates strictures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the features of Crohn’s disease observed in small bowel enema?

A

Proximal bowel dilation, ‘rose thorn’ ulcers, and fistulae.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is Crohn’s disease?

A

Crohn’s disease is a form of inflammatory bowel disease that commonly affects the terminal ileum and colon but may be seen anywhere from the mouth to anus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What guidelines were published for the management of Crohn’s disease?

A

NICE published guidelines on the management of Crohn’s disease in 2012.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What lifestyle change should patients with Crohn’s disease be advised to make?

A

Patients should be strongly advised to stop smoking.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What medications are generally used to induce remission in Crohn’s disease?

A

Glucocorticoids (oral, topical or intravenous) are generally used to induce remission.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is an alternative medication for inducing remission in a subgroup of Crohn’s disease patients?

A

Budesonide is an alternative in a subgroup of patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the role of enteral feeding in Crohn’s disease management?

A

Enteral feeding with an elemental diet may be used in addition to or instead of other measures to induce remission, particularly if there is concern regarding the side-effects of steroids.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are 5-ASA drugs used for in Crohn’s disease?

A

5-ASA drugs (e.g. mesalazine) are used second-line to glucocorticoids but are not as effective.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What medications may be used as add-on therapy to induce remission in Crohn’s disease?

A

Azathioprine or mercaptopurine may be used as an add-on medication to induce remission but are not used as monotherapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the role of infliximab in Crohn’s disease?

A

Infliximab is useful in refractory disease and fistulating Crohn’s.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is the first-line medication to maintain remission in Crohn’s disease?

A

Azathioprine or mercaptopurine is used first-line to maintain remission.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What should be assessed before starting azathioprine or mercaptopurine?

A

+TPMT activity should be assessed before starting.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What percentage of patients with Crohn’s disease will eventually have surgery?

A

Around 80% of patients with Crohn’s disease will eventually have surgery.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What is the investigation of choice for suspected perianal fistulae?

A

MRI is the investigation of choice for suspected perianal fistulae.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What is a draining seton used for?

A

A draining seton is used for complex fistulae.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What are the risks associated with Crohn’s disease?

A

Patients are at risk of small bowel cancer, colorectal cancer, and osteoporosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What is the standard incidence ratio for small bowel cancer in Crohn’s disease?

A

The standard incidence ratio for small bowel cancer is 40.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What is the standard incidence ratio for colorectal cancer in Crohn’s disease?

A

The standard incidence ratio for colorectal cancer is 2.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What are the two main types of inflammatory bowel disease?

A

Crohn’s disease and ulcerative colitis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What is a common symptom of Crohn’s disease?

A

Diarrhoea usually non-bloody.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What is a prominent symptom of ulcerative colitis?

A

Bloody diarrhoea more common.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What extra-intestinal manifestation is more common in Crohn’s disease?

A

Gallstones are more common secondary to reduced bile acid reabsorption.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What is a complication associated with Crohn’s disease?

A

Obstruction, fistula, colorectal cancer.

38
Q

What is a complication associated with ulcerative colitis?

A

Risk of colorectal cancer is higher in UC than CD.

39
Q

Where can lesions be seen in Crohn’s disease?

A

Lesions may be seen anywhere from the mouth to anus.

40
Q

How does inflammation spread in ulcerative colitis?

A

Inflammation always starts at the rectum and never spreads beyond the ileocaecal valve.

41
Q

What histological feature is common in Crohn’s disease?

A

Granulomas.

42
Q

What histological feature is common in ulcerative colitis?

A

No inflammation beyond submucosa (unless fulminant disease).

43
Q

What endoscopic appearance is associated with Crohn’s disease?

A

Deep ulcers, skip lesions - ‘cobble-stone’ appearance.

44
Q

What endoscopic appearance is associated with ulcerative colitis?

A

Widespread ulceration with preservation of adjacent mucosa which has the appearance of polyps (‘pseudopolyps’).

45
Q

What radiological sign is associated with Crohn’s disease?

A

‘Kantor’s string sign’ for strictures.

46
Q

What radiological finding is associated with ulcerative colitis?

A

Loss of haustrations.

47
Q

Which extra-intestinal manifestation is much more common in ulcerative colitis than in Crohn’s disease?

A

Primary sclerosing cholangitis.

48
Q

What is ulcerative colitis (UC)?

A

Ulcerative colitis (UC) is a form of inflammatory bowel disease.

49
Q

Where does inflammation in ulcerative colitis start?

A

Inflammation always starts at the rectum.

50
Q

Does ulcerative colitis spread beyond the ileocaecal valve?

A

No, it never spreads beyond the ileocaecal valve.

51
Q

What is the peak incidence age range for ulcerative colitis?

A

The peak incidence is in people aged 15-25 years and 55-65 years.

52
Q

What are the initial symptoms of ulcerative colitis?

A

Symptoms include bloody diarrhoea, urgency, tenesmus, and abdominal pain, particularly in the left lower quadrant.

53
Q

What is the preferred method for diagnosing ulcerative colitis?

A

Colonoscopy + biopsy is generally done for diagnosis.

54
Q

What should be avoided in patients with severe colitis?

A

Colonoscopy should be avoided due to the risk of perforation; a flexible sigmoidoscopy is preferred.

55
Q

What are typical endoscopic findings in ulcerative colitis?

A

Typical findings include red, raw mucosa that bleeds easily, no inflammation beyond submucosa (unless fulminant disease), and widespread ulceration with preservation of adjacent mucosa.

56
Q

What is a characteristic feature of long-standing ulcerative colitis seen in a barium enema?

A

The colon appears narrow and short, described as ‘drainpipe colon’.

57
Q

What are common extra-intestinal features of inflammatory bowel disease?

A

Common features include arthritis (pauciarticular, asymmetric), erythema nodosum, episcleritis, and osteoporosis.

58
Q

Which extra-intestinal feature is most common in both Crohn’s disease and ulcerative colitis?

A

Arthritis is the most common extra-intestinal feature.

59
Q

Which extra-intestinal feature is more common in Crohn’s disease?

A

Episcleritis is more common in Crohn’s disease.

60
Q

What are extra-intestinal features unrelated to disease activity?

A

These include polyarticular, symmetric arthritis, uveitis, pyoderma gangrenosum, clubbing, and primary sclerosing cholangitis.

61
Q

What is the risk of colorectal cancer in ulcerative colitis patients compared to the general population?

A

The risk of colorectal cancer is significantly higher than that of the general population, although studies report widely varying rates.

62
Q

What is the main reason for the increased risk of colorectal cancer in ulcerative colitis patients?

A

The increased risk is mainly related to chronic inflammation.

63
Q

How does the prognosis of ulcerative colitis patients compare to those without the condition?

A

Ulcerative colitis patients have a worse prognosis than patients without ulcerative colitis, partly due to delayed diagnosis.

64
Q

What is a characteristic of lesions in ulcerative colitis?

A

Lesions may be multifocal.

65
Q

What factors increase the risk of cancer in ulcerative colitis patients?

A

Factors include disease duration > 10 years, patients with pancolitis, onset before 15 years old, unremitting disease, and poor compliance to treatment.

66
Q

How should colonoscopy surveillance be determined in inflammatory bowel disease patients?

A

Colonoscopy surveillance should be decided following risk stratification.

67
Q

What is the follow-up for lower risk patients?

A

Lower risk patients should have a 5 year follow up colonoscopy if they have extensive colitis with no active endoscopic/histological inflammation, left sided colitis, or Crohn’s colitis of <50% colon.

68
Q

What is the follow-up for intermediate risk patients?

A

Intermediate risk patients should have a 3 year colonoscopy if they have extensive colitis with mild active endoscopy/histological inflammation, post-inflammatory polyps, or a family history of colorectal cancer in a first degree relative aged 50 or over.

69
Q

What is the follow-up for higher risk patients?

A

Higher risk patients should have a 1 year follow up colonoscopy if they have extensive colitis with moderate/severe active endoscopic/histological inflammation, a stricture in the past 5 years, dysplasia in the past 5 years declining surgery, primary sclerosing cholangitis, or a family history of colorectal cancer in first degree relatives aged <50 years.

70
Q

What are common triggers for ulcerative colitis flares?

A

Most ulcerative colitis flares occur without an identifiable trigger. However, factors often linked include stress, medications, NSAIDs, antibiotics, and cessation of smoking.

71
Q

How are flares of ulcerative colitis classified?

A

Flares are classified as mild, moderate, or severe.

72
Q

What characterizes a mild flare of ulcerative colitis?

A

Fewer than four stools daily, with or without blood. No systemic disturbance. Normal erythrocyte sedimentation rate and C-reactive protein values.

73
Q

What characterizes a moderate flare of ulcerative colitis?

A

Four to six stools a day, with minimal systemic disturbance.

74
Q

What characterizes a severe flare of ulcerative colitis?

A

More than six stools a day, containing blood. Evidence of systemic disturbance, e.g., fever, tachycardia, abdominal tenderness, distension or reduced bowel sounds, anaemia, hypoalbuminaemia.

75
Q

What should be done for patients with evidence of severe ulcerative colitis?

A

Patients with evidence of severe disease should be admitted to hospital.

76
Q

What are the two main categories of treatment for ulcerative colitis?

A

Treatment can be divided into inducing and maintaining remission.

77
Q

What are the classifications of the severity of ulcerative colitis?

A

The severity of UC is classified as mild, moderate, or severe.

78
Q

What defines mild ulcerative colitis?

A

Mild: < 4 stools/day, only a small amount of blood.

79
Q

What defines moderate ulcerative colitis?

A

Moderate: 4-6 stools/day, varying amounts of blood, no systemic upset.

80
Q

What defines severe ulcerative colitis?

A

Severe: >6 bloody stools per day + features of systemic upset (pyrexia, tachycardia, anaemia, raised inflammatory markers).

81
Q

What is the first-line treatment for mild-to-moderate proctitis?

A

Topical (rectal) aminosalicylate: rectal mesalazine is superior to rectal steroids and oral aminosalicylates.

82
Q

What should be done if remission is not achieved within 4 weeks for mild-to-moderate proctitis?

A

Add an oral aminosalicylate.

83
Q

What is the treatment approach for proctosigmoiditis and left-sided ulcerative colitis if remission is not achieved within 4 weeks?

A

Add a high-dose oral aminosalicylate OR switch to a high-dose oral aminosalicylate and a topical corticosteroid.

84
Q

What is the treatment for extensive disease if remission is not achieved within 4 weeks?

A

Stop topical treatments and offer a high-dose oral aminosalicylate and an oral corticosteroid.

85
Q

How should severe colitis be treated?

A

Severe colitis should be treated in hospital with IV steroids as first-line.

86
Q

What should be considered if there is no improvement after 72 hours of treatment for severe colitis?

A

Consider adding IV ciclosporin to IV corticosteroids or consider surgery.

87
Q

What is the maintenance treatment following a mild-to-moderate ulcerative colitis flare for proctitis and proctosigmoiditis?

A

Topical (rectal) aminosalicylate alone or an oral aminosalicylate plus a topical (rectal) aminosalicylate.

88
Q

What is the recommended maintenance treatment for left-sided and extensive ulcerative colitis?

A

Low maintenance dose of an oral aminosalicylate.

89
Q

What should be done following a severe relapse or >=2 exacerbations in the past year?

A

Oral azathioprine or oral mercaptopurine.

90
Q

Is methotrexate recommended for the management of ulcerative colitis?

A

No, methotrexate is not recommended for the management of UC.

91
Q

What evidence exists regarding probiotics in ulcerative colitis?

A

There is some evidence that probiotics may prevent relapse in patients with mild to moderate disease.